Compare · MTD vs PRPO
MTD vs PRPO
Side-by-side comparison of Mettler-Toledo International Inc. (MTD) and Precipio Inc. (PRPO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MTD and PRPO operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- MTD is the larger of the two at $23.06B, about 570.2x PRPO ($40.4M).
- Over the past year, MTD is down 4.2% and PRPO is up 105.0% - PRPO leads by 109.2 points.
- PRPO has been more active in the news (3 items in the past 4 weeks vs 2 for MTD).
- MTD has more recent analyst coverage (23 ratings vs 0 for PRPO).
- Company
- Mettler-Toledo International Inc.
- Precipio Inc.
- Price
- $1139.65+0.54%
- $22.96+0.31%
- Market cap
- $23.06B
- $40.4M
- 1M return
- +6.24%
- -19.44%
- 1Y return
- -4.15%
- +105.00%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 1997
- News (4w)
- 2
- 3
- Recent ratings
- 23
- 0
Mettler-Toledo International Inc.
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications. Its laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform. The company's industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, and product inspection systems. Its retail weighing solutions consist of networked scales and software, and stand-alone scales for handling fresh goods, such as meats, vegetables, fruits, and cheeses. The company serves the life science industry, and independent research organizations; food and beverage producers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community. It markets its products through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Precipio Inc.
Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test; and ICE-COLD-PCR enables detection of abnormalities in blood samples. The company also operates a cancer diagnostic laboratory located in New Haven, Connecticut. It sells ICE-COLD-PCR technology kits to bio-pharma customers, clinical research, HemeScreen, and COVID-19 antibody tests. The company serves oncologists, hospitals, reference laboratories, physician-office labs, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania. The company is based in New Haven, Connecticut.
Latest MTD
- Wolfe Research resumed coverage on Mettler-Toledo
- SEC Form SD filed by Mettler-Toledo International Inc.
- Head of Asia & Pacific Wong Ann Ping Richard was granted 103 shares, increasing direct ownership by 19% to 645 units (SEC Form 4)
- Head of PI, Retail, and GSC Wittorf Oliver was granted 87 shares, increasing direct ownership by 21% to 495 units (SEC Form 4)
- Chief Financial Officer Vadala Shawn was granted 291 shares, increasing direct ownership by 6% to 5,579 units (SEC Form 4)
- Head of Process Analytics Keller Gerry was granted 100 shares, increasing direct ownership by 63% to 259 units (SEC Form 4)
- President and CEO Kaltenbach Patrick was granted 810 shares, increasing direct ownership by 22% to 4,480 units (SEC Form 4)
- Chief Human Resources Officer Graham-Bryce Susan was granted 71 shares, increasing direct ownership by 16% to 517 units (SEC Form 4)
- Mettler-Toledo International Inc. filed SEC Form 8-K: Leadership Update
- Mettler-Toledo International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Latest PRPO
- Precipio to Present at the Planet MicroCap Las Vegas
- Director Sandberg Richard A sold $22,517 worth of shares (900 units at $25.02) (SEC Form 4)
- Director Sandberg Richard A sold $77,784 worth of shares (3,134 units at $24.82), decreasing direct ownership by 20% to 8,142 units (SEC Form 4)
- Precipio Announces Q1 2026 Financial Results
- SEC Form 10-Q filed by Precipio Inc.
- Management team's 2025 market-based Options have vested
- Precipio Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Precipio Announces Q1-2026 Shareholder Update Call
- SEC Form DEFA14A filed by Precipio Inc.
- SEC Form DEF 14A filed by Precipio Inc.